H Jeffrey Wilkins
CIK 1779160 · Chief Medical Officer · last filed 2021-12-14
H Jeffrey Wilkins is a Chief Medical Officer who has filed 3 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider bought $10.0K of AVTX on Dec 14, 2021. Across all open-market trades the lifetime net is +$12.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $492.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$492.6K
2
3
$12.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVTX | Chief Medical Officer | 33,373 | $14.76 | $492.6K | $10.0K | 1 | 2021-12-14 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Chief Medical Officer | 27,002 | $2.93 | $79.1K | $2.1K | 1 | 2021-06-14 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-12-14 | AVTX | Buy (P) | +6,371 | $10.0K | EDGAR |
| 2021-06-14 | Avalo Therapeutics, Inc. (CERC) Delisted | Buy (P) | +912 | $2.1K | EDGAR |
| 2019-07-01 | — | Grant (A) | +190,000 | $0 |